References

References: Science in Detail 14 · The Window, Measured in Days

  1. Vargesson N, Birth Defects Research C 105(2): 140–156, 2015.
  2. Smithells RW & Newman CGH, 'Recognition of thalidomide defects,' Journal of Medical Genetics 29(10): 716–723, 1992.
  3. Smithells RW & Newman CGH, Journal of Medical Genetics 29(10): 716–723, 1992.
  4. Lenz W, Teratology 38(3): 203–215, 1988.
  5. Stephens TD & Brynner R, 'Dark Remedy,' Perseus, 2001.
  6. Therapontos C et al., PNAS 106(21): 8573–8578, 2009.
  7. Miller MT, Stromland K, 'What can we learn from the thalidomide experience: an ophthalmologic perspective,' Current Opinion in Ophthalmology 22(5): 356-364, 2011.
  8. Vargesson N, 'Thalidomide-induced teratogenesis: history and mechanisms,' Birth Defects Research Part C 105(2): 140-156, 2015.
  9. Schwartz JM, Grimes DR (and historical review). "Two Surgeon General's reports on smoking and cancer: a historical investigation of the practice of causal inference." (PMC1343554).
  10. Cornfield J et al. "Smoking and lung cancer: recent evidence and a discussion of some questions." J Natl Cancer Inst 22:173-203, 1959.
  11. US Surgeon General. Smoking and Health: Report of the Advisory Committee to the Surgeon General of the Public Health Service. PHS Publication No. 1103, 1964.
  12. Doll R, Hill AB. 'Smoking and carcinoma of the lung.' British Medical Journal 2(4682):739-748 (1950).